Arcus Biosciences, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↓-1.0% -$11M
$1.14B
Current Assets↓-0.9% -$9M
$1.01B
Cash & Equivalents↑+48.0% +$72M
$222M
ST Investments
—
Net PPE↓-14.9% -$7M
$40M
Total Liabilities
—
Current Liabilities↑+2.2% +$5M
$231M
Account Payables↑+133.3% +$24M
$42M
Long-Term Debt↑+106.3% +$51M
$99M
Stockholders Equity↑+30.1% +$146M
$631M
Retained Earnings↓-31.2% -$353M
$-1.49B
Operating Lease ROU Asset↓-10.8% -$7M
$58M
Operating Lease Liability↑+0.0% +$0
$99M
Gross PP&E↑+2.3% +$2M
$90M
Accumulated Depreciation↑+22.0% +$9M
$50M
Total Debt Carrying Amount↑+100.0% +$50M
$100M
Contract Asset↓-45.0% -$9M
$11M
Contract Liability↓-75.5% -$241M
$78M
Contract Liability (Current)↓-58.8% -$50M
$35M
Contract Liability (Noncurrent)↓-81.6% -$191M
$43M
Remaining Performance Obligation↓-51.0% -$266M
$256M